Clinical Trial Update: Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck [NA]

View source ↗

Summary

This clinical trial update reports the completion and posted results of a pilot study evaluating AuroLase photothermal therapy for refractory or recurrent head …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• AuroLase

Snippet

Sponsor: Nanospectra Biosciences, Inc. | Conditions: Head and Neck Cancer | NA | Status: COMPLETED | Results posted: 2016-07-18